T1	Procedure 50 76	myeloablative conditioning
T2	Procedure-Name 50 76	myeloablative conditioning
E1	Procedure:T1 Name:T2 Temporality:E2 Temporality2:E4
T3	Condition 89 92	HCT
T4	Condition-Name 89 92	HCT
E3	Condition:T3 Name:T4
T5	Observation 168 171	TBI
T6	Observation-Name 168 171	TBI
E5	Observation:T5 Name:T6 Eq-Comparison:E42
T7	Observation 228 231	TBI
T8	Observation-Name 228 231	TBI
E7	Observation:T7 Name:T8 Eq-Comparison:E43 Eq-Comparison2:E44
T9	Observation 321 324	TBI
T10	Observation-Name 321 324	TBI
E9	Observation:T9 Name:T10 Eq-Comparison:E45 Eq-Comparison2:E46
T11	Observation 414 417	TBI
T12	Observation-Name 414 417	TBI
E11	Observation:T11 Name:T12 Eq-Comparison:E47 Eq-Comparison2:E48
T13	Procedure 906 932	myeloablative conditioning
T14	Procedure-Name 906 932	myeloablative conditioning
E13	Procedure:T13 Name:T14
T15	Procedure 1025 1036	prophylaxis
T16	Procedure-Name 1025 1036	prophylaxis
E15	Procedure:T15 Name:T16
T19	Condition 1020 1024	GVHD
T20	Condition-Name 1020 1024	GVHD
E19	Condition:T19 Name:T20
T23	Condition 1325 1340	steatohepatitis
T24	Condition-Name 1325 1340	steatohepatitis
E23	Condition:T23 Name:T24
T25	Condition 1139 1152	Osteopetrosis
T26	Condition-Name 1139 1152	Osteopetrosis
E25	Condition:T25 Name:T26
T27	Condition 1310 1323	iron overload
T28	Condition-Name 1310 1323	iron overload
E27	Condition:T27 Name:T28
T29	Condition 1154 1165	Thalassemia
T30	Condition-Name 1154 1165	Thalassemia
E29	Condition:T29 Name:T30
T31	Condition 1375 1384	hepatitis
T32	Condition-Name 1375 1384	hepatitis
E31	Condition:T31 Name:T32 Temporality:E102
T37	Condition 1077 1080	SOS
T38	Condition-Name 1077 1080	SOS
E37	Condition:T37 Name:T38
T39	Condition 1134 1137	HLH
T40	Condition-Name 1134 1137	HLH
E39	Condition:T39 Name:T40
T41	Condition 1462 1465	SOS
T42	Condition-Name 1462 1465	SOS
E41	Condition:T41 Name:T42
T44	Eq-Operator 172 174	>=
A1	Eq-Operator-Value T44 GTEQ
T45	Eq-Operator 233 234	>
A2	Eq-Operator-Value T45 GT
T46	Eq-Operator 255 256	>
A3	Eq-Operator-Value T46 GT
T47	Eq-Operator 326 327	>
A4	Eq-Operator-Value T47 GT
T48	Eq-Operator 348 349	>
A5	Eq-Operator-Value T48 GT
T49	Eq-Operator 419 420	>
A6	Eq-Operator-Value T49 GT
T50	Eq-Operator 441 442	>
A7	Eq-Operator-Value T50 GT
T51	Eq-Operator 498 499	>
A8	Eq-Operator-Value T51 GT
T52	Eq-Operator 516 517	>
A9	Eq-Operator-Value T52 GT
T53	Eq-Operator 584 585	>
A10	Eq-Operator-Value T53 GT
T54	Eq-Operator 601 602	>
A11	Eq-Operator-Value T54 GT
T55	Eq-Operator 663 664	>
A12	Eq-Operator-Value T55 GT
T56	Eq-Operator 680 681	>
A13	Eq-Operator-Value T56 GT
T57	Eq-Operator 760 761	>
A14	Eq-Operator-Value T57 GT
T58	Eq-Operator 781 782	>
A15	Eq-Operator-Value T58 GT
T59	Eq-Operator 1207 1213	within
A16	Eq-Operator-Value T59 LTEQ
T60	Eq-Operator 1284 1290	within
A17	Eq-Operator-Value T60 LTEQ
T61	Eq-Temporal-Unit 1216 1222	months
A18	Eq-Temporal-Unit-Value T61 month
T62	Eq-Temporal-Unit 1293 1299	months
A19	Eq-Temporal-Unit-Value T62 month
T63	Eq-Unit 507 509	kg
T64	Eq-Unit 523 525	kg
T65	Eq-Unit 592 594	kg
T66	Eq-Unit 609 611	kg
T67	Eq-Unit 671 673	kg
T68	Eq-Unit 688 690	kg
T70	Eq-Value 101 109	4/1/2019
T71	Eq-Value 114 124	12/31/2120
T72	Eq-Value 175 179	1200
T73	Eq-Value 235 238	500
T74	Eq-Value 257 260	800
T75	Eq-Value 328 331	500
T76	Eq-Value 350 353	800
T77	Eq-Value 421 424	500
T78	Eq-Value 443 446	800
T79	Eq-Value 500 503	7.2
T80	Eq-Value 517 520	9.0
T81	Eq-Value 585 588	7.2
T82	Eq-Value 602 605	9.0
T83	Eq-Value 664 667	7.2
T84	Eq-Value 681 684	9.0
T85	Eq-Value 761 763	75
T86	Eq-Value 782 787	18270
T87	Eq-Value 1214 1215	3
T89	Eq-Value 1291 1292	6
T90	Eq-Comparison 172 183	>= 1200 cGy
E42	Eq-Comparison:T90 Operator:T44 Value:T72 Unit:T114
T91	Eq-Comparison 233 242	> 500 cGy
E43	Eq-Comparison:T91 Operator:T45 Value:T73 Unit:T119
T92	Eq-Comparison 255 263	> 800cGy
E44	Eq-Comparison:T92 Operator:T46 Value:T74 Unit:T121
T93	Eq-Comparison 326 335	> 500 cGy
E45	Eq-Comparison:T93 Operator:T47 Value:T75 Unit:T130
T94	Eq-Comparison 348 357	> 800 cGy
E46	Eq-Comparison:T94 Operator:T48 Value:T76 Unit:T132
T95	Eq-Comparison 419 428	> 500 cGy
E47	Eq-Comparison:T95 Operator:T49 Value:T77 Unit:T141
T96	Eq-Comparison 441 450	> 800 cGy
E48	Eq-Comparison:T96 Operator:T50 Value:T78 Unit:T142
T97	Eq-Comparison 498 509	> 7.2 mg/kg
E49	Eq-Comparison:T97 Operator:T51 Value:T79 Unit:T148 Per:T63
T98	Eq-Comparison 516 520	>9.0
E50	Eq-Comparison:T98 Operator:T52 Value:T80 Unit:T151 Per:T64
T99	Eq-Comparison 584 594	>7.2 mg/kg
E51	Eq-Comparison:T99 Operator:T53 Value:T81 Unit:T158 Per:T65
T100	Eq-Comparison 601 611	>9.0 mg/kg
E52	Eq-Comparison:T100 Operator:T54 Value:T82 Unit:T160 Per:T66
T101	Eq-Comparison 663 673	>7.2 mg/kg
E53	Eq-Comparison:T101 Operator:T55 Value:T83 Unit:T168 Per:T67
T102	Eq-Comparison 680 690	>9.0 mg/kg
E54	Eq-Comparison:T102 Operator:T56 Value:T84 Unit:T170 Per:T68
T103	Eq-Comparison 760 777	>75 mg/L per hour
E55	Eq-Comparison:T103 Operator:T57 Value:T85 Unit:T179 Per:T180 Per2:T181
T104	Eq-Comparison 781 809	>18270 microMolar per minute
E56	Eq-Comparison:T104 Operator:T58 Value:T86 Unit:T182 Per:T183
T105	Eq-Comparison 1207 1222	within 3 months
E57	Eq-Comparison:T105 Operator:T59 Temporal-Unit:T61 Value:T87
T106	Eq-Comparison 1284 1299	within 6 months
E58	Eq-Comparison:T106 Operator:T60 Temporal-Unit:T62 Value:T89
T107	Eq-Comparison 37 47	undergoing
E2	Eq-Comparison:T107 Temporal-Period:T108
T108	Eq-Temporal-Period 37 47	undergoing
A20	Eq-Temporal-Period-Value T108 present
R1	Treatment-For Arg1:E1 Arg2:E3	
T109	Eq-Comparison 93 124	between 4/1/2019 and 12/31/2120
E4	Eq-Comparison:T109 Operator:T110 Value:T70 Value2:T71
T110	Eq-Operator 93 100	between
A21	Eq-Operator-Value T110 BETWEEN
T111	Eq-Comparison 136 139	one
E6	Eq-Comparison:T111 Value:T112
T112	Eq-Value 136 139	one
T113	Criteria-Count 143 156	the following
E8	Criteria-Count:T113 Min-Value:E6 Criteria:E5 Criteria3:E22 Criteria2:E12 Criteria4:E36 Criteria5:E63 Criteria6:E69 Criteria7:E75 Criteria8:E81
A22	Observation-Type-Value T6 lab
T114	Eq-Unit 180 183	cGy
T115	Modifier 185 197	fractionated
E10	Modifier:T115 Modifies:E42
R2	Equivalent-To Arg1:E8 Arg2:E1	
T116	Drug 209 225	Cyclophosphamide
E12	Drug:T116 Name:T117
T117	Drug-Name 209 225	Cyclophosphamide
T118	And 226 227	+
E14	And:T118 Arg:E12 Arg2:E7
A23	Observation-Type-Value T8 lab
T119	Eq-Unit 239 242	cGy
T120	Modifier 244 250	single
E16	Modifier:T120 Modifies:E43
T121	Eq-Unit 260 263	cGy
T122	Or 252 254	or
E18	Or:T122 Arg:E43 Arg2:E44
T123	Modifier 265 277	fractionated
E20	Modifier:T123 Modifies:E44
T124	Drug 290 306	Cyclophosphamide
E22	Drug:T124 Name:T125
T125	Drug-Name 290 306	Cyclophosphamide
T126	Drug 309 318	Etoposide
E24	Drug:T126 Name:T127
T127	Drug-Name 309 318	Etoposide
T128	And 307 308	+
E26	And:T128 Arg:E22 Arg2:E24
A24	Observation-Type-Value T10 lab
T129	And 319 320	+
E28	And:T129 Arg:E24 Arg2:E9
T130	Eq-Unit 332 335	cGy
T131	Modifier 337 343	single
E30	Modifier:T131 Modifies:E45
T132	Eq-Unit 354 357	cGy
T133	Modifier 359 371	fractionated
E32	Modifier:T133 Modifies:E46
T134	Or 345 347	or
E34	Or:T134 Arg:E45 Arg2:E46
T135	Drug 384 400	Cyclophosphamide
E36	Drug:T135 Name:T136
T136	Drug-Name 384 400	Cyclophosphamide
T137	Drug 403 411	Thiotepa
E38	Drug:T137 Name:T138
T138	Drug-Name 403 411	Thiotepa
A25	Observation-Type-Value T12 lab
T139	And 401 402	+
E40	And:T139 Arg:E36 Arg2:E38
T140	And 412 413	+
E59	And:T140 Arg:E38 Arg2:E11
T141	Eq-Unit 425 428	cGy
T142	Eq-Unit 447 450	cGy
T143	Modifier 430 436	single
E60	Modifier:T143 Modifies:E47
T144	Modifier 452 464	fractionated
E61	Modifier:T144 Modifies:E48
T145	Or 438 440	or
E62	Or:T145 Arg:E47 Arg2:E48
T146	Drug 477 485	Busulfan
E63	Drug:T146 Name:T147 Dose:E49 Dose2:E50
T147	Drug-Name 477 485	Busulfan
T148	Eq-Unit 504 506	mg
T149	Modifier 510 512	IV
E64	Modifier:T149 Modifies:E49
T150	Modifier 526 532	orally
E65	Modifier:T150 Modifies:E50
T151	Eq-Unit 520 522	mg
T152	Or 513 515	or
E66	Or:T152 Arg:E49 Arg2:E50
T153	Drug 536 552	Cyclophosphamide
E67	Drug:T153 Name:T154
T154	Drug-Name 536 552	Cyclophosphamide
T155	And 534 535	+
E68	And:T155 Arg:E63 Arg2:E67
T156	Drug 563 571	Busulfan
E69	Drug:T156 Name:T157 Dose:E51 Dose2:E52
T157	Drug-Name 563 571	Busulfan
T158	Eq-Unit 589 591	mg
T159	Modifier 595 597	IV
E70	Modifier:T159 Modifies:E51
T160	Eq-Unit 606 608	mg
T161	Or 598 600	or
E71	Or:T161 Arg:E51 Arg2:E52
T162	Modifier 612 618	orally
E72	Modifier:T162 Modifies:E52
T163	Drug 622 631	Melphalan
E73	Drug:T163 Name:T164
T164	Drug-Name 622 631	Melphalan
T165	And 620 621	+
E74	And:T165 Arg:E69 Arg2:E73
T166	Drug 642 650	Busulfan
E75	Drug:T166 Name:T167 Dose:E53 Dose2:E54
T167	Drug-Name 642 650	Busulfan
T168	Eq-Unit 668 670	mg
T169	Modifier 674 676	IV
E76	Modifier:T169 Modifies:E53
T170	Eq-Unit 685 687	mg
T171	Modifier 691 697	orally
E77	Modifier:T171 Modifies:E54
T172	Or 677 679	or
E78	Or:T172 Arg:E53 Arg2:E54
T173	Drug 701 709	Thiotepa
E79	Drug:T173 Name:T174
T174	Drug-Name 701 709	Thiotepa
T175	And 699 700	+
E80	And:T175 Arg:E75 Arg2:E79
T69	Drug 726 734	Busulfan
E81	Drug:T69 Name:T176
T176	Drug-Name 726 734	Busulfan
T177	Observation 735 756	cumulative plasma AUC
E82	Observation:T177 Name:T178 Eq-Comparison:E55 Eq-Comparison2:E56
T178	Observation-Name 735 756	cumulative plasma AUC
A26	Observation-Type-Value T178 lab
T179	Eq-Unit 764 766	mg
T180	Eq-Unit 767 768	L
T181	Eq-Temporal-Unit 773 777	hour
A27	Eq-Temporal-Unit-Value T181 hour
T182	Eq-Unit 788 798	microMolar
T183	Eq-Temporal-Unit 803 809	minute
A28	Eq-Temporal-Unit-Value T183 minute
T184	Or 778 780	or
E83	Or:T184 Arg:E55 Arg2:E56
T185	Or 878 880	OR
E84	Or:T185 Arg:E8 Arg2:E13
T17	Drug 991 1000	sirolimus
E17	Drug:T17 Name:T18
T18	Drug-Name 991 1000	sirolimus
T186	Drug 1005 1015	tacrolimus
E85	Drug:T186 Name:T187
T187	Drug-Name 1005 1015	tacrolimus
R3	Treatment-For Arg1:E15 Arg2:E19	
R4	Using Arg1:E15 Arg2:E85	
R5	Using Arg1:E15 Arg2:E17	
T188	Or 1001 1004	and
E86	Or:T188 Arg:E17 Arg2:E85
R6	Using Arg1:E13 Arg2:E15	
T189	Risk 1068 1072	risk
E87	Risk:T189 Polarity:T21 Risk-For:E37
T21	Polarity 1063 1067	high
A29	Polarity-Value T21 high
T22	Or 1038 1040	OR
E21	Or:T22 Arg:E13 Arg2:E87
T190	Condition 1119 1132	Neuroblastoma
E88	Condition:T190 Name:T191
T191	Condition-Name 1119 1132	Neuroblastoma
T33	Procedure 1167 1176	treatment
E33	Procedure:T33 
T34	Drug 1182 1192	inotuzumab
E35	Drug:T34 Name:T35
T35	Drug-Name 1182 1192	inotuzumab
R7	Using Arg1:E33 Arg2:E35	
T36	Drug 1196 1206	gemtuzumab
E89	Drug:T36 Name:T88 Temporality:E57
T88	Drug-Name 1196 1206	gemtuzumab
T192	Or 1193 1195	or
E90	Or:T192 Arg:E35 Arg2:E89
T193	Encounter 1237 1246	admission
E91	Encounter:T193 Type:T194
T194	Encounter-Type 1237 1246	admission
A30	Encounter-Type-Value T194 inpatient
T195	Procedure 1232 1236	HSCT
E92	Procedure:T195 Name:T196
T196	Procedure-Name 1232 1236	HSCT
R8	Using Arg1:E91 Arg2:E92	
T197	Temporal-Connection 1223 1231	prior to
E93	Temporal-Connection:T197 Arg:E57 Arg2:E91
A31	Temporal-Connection-Type-Value E93 before
T198	Eq-Comparison 1248 1251	2nd
E94	Eq-Comparison:T198 Value:T199
T199	Eq-Value 1248 1251	2nd
T200	Procedure 1252 1256	HSCT
E95	Procedure:T200 Name:T201 Minimum-Count:E94 Temporality:E58
T201	Procedure-Name 1252 1256	HSCT
T202	Modifier 1266 1279	myeloablative
E96	Modifier:T202 Modifies:T201
T203	Coreference 1303 1308	prior
E97	Coreference:T203 Refers-To:E95
T204	Temporal-Connection 1300 1302	of
E98	Temporal-Connection:T204 Arg:E58 Arg2:E97
A32	Temporal-Connection-Type-Value E98 before
T205	Modifier 1365 1374	infection
E99	Modifier:T205 Modifies:T32
T206	Modifier 1349 1361	inflammatory
E100	Modifier:T206 Modifies:T32
T207	Or 1362 1364	or
E101	Or:T207 Arg:E100 Arg2:E99
T208	Eq-Comparison 1342 1348	active
E102	Eq-Comparison:T208 Temporal-Period:T209
T209	Eq-Temporal-Period 1342 1348	active
A33	Eq-Temporal-Period-Value T209 present
T210	Condition 1398 1407	condition
E103	Condition:T210 
T211	Other 1392 1397	other
E104	Other:T211 Is-Other:E103
T212	Or 1385 1387	or
E105	Or:T212 Arg:E31 Arg2:E103
T213	Risk 1443 1447	risk
E106	Risk:T213 Polarity:T214 Risk-For:E41 Stability:T215
T214	Polarity 1436 1442	higher
A34	Polarity-Value T214 high
T215	Stability 1414 1418	puts
A35	Stability-Value T215 change
R9	Caused-By Arg1:T215 Arg2:E103	
T43	Procedure 1532 1538	US SWE
E107	Procedure:T43 Name:T216
T216	Procedure-Name 1532 1538	US SWE
T217	Contraindication 1512 1528	contraindication
E108	Contraindication:T217 Contraindicates:E107
T218	Condition 1545 1565	unable to hold still
E109	Condition:T218 Name:T219
T219	Condition-Name 1545 1565	unable to hold still
R10	Example-Of Arg1:E109 Arg2:E108
